Search

Your search keyword '"Kleine-Tebbe, J."' showing total 578 results

Search Constraints

Start Over You searched for: Author "Kleine-Tebbe, J." Remove constraint Author: "Kleine-Tebbe, J."
578 results on '"Kleine-Tebbe, J."'

Search Results

2. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

17. Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

19. Leitlinie zur Allergen-Immuntherapie bei IgE-vermittelten allergischen Erkrankungen

20. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

21. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

23. Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

26. One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence

28. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

33. Placebo effects in allergen immunotherapy—An EAACI Task Force Position Paper

34. Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany

37. COVID-19-Impfungen von allergischen Patienten im zeitlichen Zusammenhang mit einer Allergen-Immuntherapie (AIT) – Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für Allergologie und Klin

38. COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika) – Ein Positionspapier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) u

39. Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie – ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion)

40. Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie : Ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion)

41. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

42. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B<

43. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

44. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic [Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie]

46. Allergen immuntherapy in the current COVID-19 pandemic - A position paper of ARIA, EAACI, AeDA, DGAKI, and GPA

47. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID 19 pandemic

48. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA- EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)

49. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

50. Praktische Empfehlungen zur allergologischen Risikoabschätzung der COVID- 19-Impfung

Catalog

Books, media, physical & digital resources